25.11.2012 14:00:00

New LOGIQ E9 with XDclear from GE Healthcare Boosts Image Quality and Enhances Diagnostic Confidence

Today at RSNA 2012, GE Healthcare (NYSE: GE) is introducing the new LOGIQ* E9 with XDclear, a new general imaging ultrasound system. Built from the acclaimed LOGIQ E9 platform, new features on the company’s premium product allow for increased penetration on large patients, improved clarity and diagnostic confidence.1

"Because ultrasound imaging is one of the pillars for disease assessment and determining treatment options - image quality, clinical capability and procedure accuracy are paramount. Advancements in the new LOGIQ E9 with XDclear platform build upon what customers have come to expect from GE Ultrasound. We’ve added innovative capabilities to help address the ultrasound exam volume and imaging challenges that clinicians face every day,” said Brian McEathron, General Manager of General Imaging Ultrasound for GE Healthcare.

Enhanced Image Quality

Because of advances in acoustic engineering used in new XDclear transducer technology, users of the new C1-6 and C2-9 transducers experience increased penetration of 2-4 cm1 while simultaneously experiencing high definition resolution throughout the image.

On the new LOGIQ E9 with XDclear, the company has also added its innovative B-Flow* imaging capability.

This GE imaging mode uses non-Doppler technology to display true hemodynamics and enables direct visualization of blood flow without the limitations of Doppler.

Enhanced workflow

In addition to a larger, adjustable monitor,1 a faster computer1 and enhanced ergonomics, GE Healthcare has added features including Compare Assistant plus Breast and Thyroid Productivity Packages to help improve overall workflow.1 Compare Assistant helps streamline comparison exams while the Productivity Packages help ease the burden of measurement-heavy studies.

Volume Navigation

The LOGIQ E9 with XDclear includes an expansion of Volume Navigation capabilities with new tools and accessories such as automatic CT registration.

* Trademark of General Electric Company.

GE Healthcare at RSNA 2012

Each year in Chicago, the conference of the Radiological Association of North America (RSNA) provides a forum for showcasing the latest innovations in medical imaging. If you are attending the conference, please visit GE Healthcare at booth number 5433 in McCormick Place south hall. Throughout the week of the event, GE Healthcare will distribute news and information using these digital platforms:

  • Digital press kit: newsroom.gehealthcare.com/press-kits/ge-healthcare-at-rsna-2012
  • Twitter: @GEHealthcare and hashtag #GEWorks
  • YouTube channel: www.youtube.com/gehealthcare
  • Flickr: www.flickr.com/people/gehealthcare
  • Instagram: instagram.com/generalelectric

###

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on increasing access and improving quality and affordability around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com. For our latest news, please visit http://newsroom.gehealthcare.com.

1 As compared to GE’s LOGIQ E9 BT11

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu General Electric Co.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

Dow Jones 42 635,20 0,25%
S&P 500 5 918,25 0,16%
S&P 100 2 903,25 0,06%
NYSE US 100 16 447,86 0,76%